منابع مشابه
Propranolol for Infantile Hemangiomas
Hemangiomas are common vascular birthmarks that usually present a predictable pattern of proliferation and ultimate involution. Most do not require any treatment. When intervention is clinically indicated, medical and surgical options exist. Historically, corticosteroids have been used and have been shown to slow or stop the growth of a majority of hemangiomas; however, growth concerns and infe...
متن کاملInfantile hemangiomas: new frontiers.
Guest Editorial I t is a very exciting time for clini-cians who are confronted with infantile hemangiomas. So much new information is now available regarding pathogenesis, epidemiology, differential diagnosis, and therapy. These aspects are reviewed in greater detail in the accompanying articles by a group of experienced scientists and clinicians, who help provide a richer and more sophisticate...
متن کاملNovel treatment for infantile hemangiomas.
Evidence Oral propranolol • In an RCT (40 children, aged 9 weeks to 5 years, followed for 6 months),1 2 mg/kg of propranolol (divided 3 times daily) stopped IH growth by week 4 for all children and reduced IH volume at all weeks compared with placebo (eg, -48.5% vs 17.9% in week 12, P = .03). No significant hypotension, hypoglycemia, or bradycardia were reported. • In a systematic review of 40 ...
متن کاملInfantile hemangiomas, complications and treatments.
Infantile hemangiomas (IHs) are the most common vascular tumors of infancy. While the majority regress without the need for intervention, approximately 10%, often site dependent, can cause serious complications and require treatment. IH complications can be categorized as life threatening, obstructive, ulcerative or disfiguring. Life threatening complications include airway and hepatic IHs. Fun...
متن کاملRCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
OBJECTIVE Timolol maleate 0.5% gel is a safe and effective medication for treating superficial infantile hemangiomas (IHs) in infants with a median age of 9 weeks. METHODS Forty-one infants who had superficial IHs without ulceration and not near mucosal surfaces were recruited and randomly assigned to placebo and treatment (timolol maleate 0.5% gel) groups. Efficacy was assessed by performing...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Serbian Journal of Dermatology and Venereology
سال: 2019
ISSN: 2406-0631,1821-0902
DOI: 10.2478/sjdv-2019-0003